You are currently viewing a new version of our website. To view the old version click .
Journal: CancersVolume: 16Number: 2287
Article: Reasonability of Frequent Laboratory Analyses during Therapy with Nivolumab and Nivolumab+Ipilimumab in Patients with Advanced or Metastatic Renal Cell Carcinoma during the Phase 2 Clinical Trial TITAN-RCC
  • Authors:
  • Klara Franke1,2,
  • Susan Foller1,2 and
  • Michele Estephania Rosero Moreno1,2
  • et al.
Link: https://www.mdpi.com/2072-6694/16/12/2287

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.